BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12608780)

  • 1. An approach to the synthesis of the phomoidrides.
    Bio MM; Leighton JL
    J Org Chem; 2003 Mar; 68(5):1693-700. PubMed ID: 12608780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations into the production and interconversion of phomoidrides A-D.
    Spencer P; Agnelli F; Sulikowski GA
    Org Lett; 2001 May; 3(10):1443-5. PubMed ID: 11388837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of the CP-molecules (CP-263,114 and CP-225,917, phomoidrides B and A). 2. Model studies for the construction of key structural elements and first-generation strategy.
    Nicolaou KC; Baran PS; Zhong YL; Fong KC; Choi HS
    J Am Chem Soc; 2002 Mar; 124(10):2190-201. PubMed ID: 11878973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of the CP-molecules (CP-263,114 and CP-225,917, phomoidrides B and A). 3. Completion and synthesis of advanced analogues.
    Nicolaou KC; Zhong YL; Baran PS; Jung J; Choi HS; Yoon WH
    J Am Chem Soc; 2002 Mar; 124(10):2202-11. PubMed ID: 11878974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
    Mitsch A; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Synthesis of (±)-Phomoidride D.
    Leung JC; Bedermann AA; Njardarson JT; Spiegel DA; Murphy GK; Hama N; Twenter BM; Dong P; Shirahata T; McDonald IM; Inoue M; Taniguchi N; McMahon TC; Schneider CM; Tao N; Stoltz BM; Wood JL
    Angew Chem Int Ed Engl; 2018 Feb; 57(7):1991-1994. PubMed ID: 29286556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward a biomimetic synthesis of phomoidride B.
    Sulikowski GA; Liu W; Agnelli F; Corbett RM; Luo Z; Hershberger SJ
    Org Lett; 2002 May; 4(9):1451-4. PubMed ID: 11975601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
    Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiospecific total synthesis of the squalene synthase inhibitors (-)-CJ-13,982 and its enantiomer from a common intermediate.
    Sturgess D; Chen Z; White JM; Rizzacasa MA
    J Antibiot (Tokyo); 2018 Feb; 71(2):234-239. PubMed ID: 29066794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new synthetic route to phomoidride B and its derivatives.
    Hayashi Y; Itoh T; Fukuyama T
    Org Lett; 2003 Jun; 5(13):2235-8. PubMed ID: 12816417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CP-225,917 and CP-263,114, novel Ras farnesylation inhibitors from an unidentified fungus. I. Taxonomy, fermentation, isolation, and biochemical properties.
    Dabrah TT; Harwood HJ; Huang LH; Jankovich ND; Kaneko T; Li JC; Lindsey S; Moshier PM; Subashi TA; Therrien M; Watts PC
    J Antibiot (Tokyo); 1997 Jan; 50(1):1-7. PubMed ID: 9066758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandem mass spectrum of a farnesyl transferase inhibitor--gas-phase rearrangements involving imidazole.
    Qin XZ
    J Mass Spectrom; 2001 Aug; 36(8):911-7. PubMed ID: 11523090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors.
    Li Q; Woods KW; Wang W; Lin NH; Claiborne A; Gu WZ; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2033-9. PubMed ID: 15808463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and selective farnesyl transferase inhibitors.
    Millet R; Domarkas J; Houssin R; Gilleron P; Goossens JF; Chavatte P; Logé C; Pommery N; Pommery J; Hénichart JP
    J Med Chem; 2004 Dec; 47(27):6812-20. PubMed ID: 15615530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of the CP-molecules (CP-263,114 and CP-225,917, phomoidrides B and A). 1. Racemic and asymmetric synthesis of bicyclo[4.3.1] key building blocks.
    Nicolaou KC; Jung J; Yoon WH; Fong KC; Choi HS; He Y; Zhong YL; Baran PS
    J Am Chem Soc; 2002 Mar; 124(10):2183-9. PubMed ID: 11878972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Lewis acid catalyzed tropone [6+4] cycloadditions to the synthesis of the core of CP-225,917.
    Isakovic L; Ashenhurst JA; Gleason JL
    Org Lett; 2001 Dec; 3(26):4189-92. PubMed ID: 11784174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective syntheses of new analogues of the farnesyltransferase inhibitor RPR 130401.
    Pichon N; Harrison-Marchand A; Mailliet P; Maddaluno J
    J Org Chem; 2004 Oct; 69(21):7220-7. PubMed ID: 15471472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase.
    Wang GT; Wang X; Wang W; Hasvold LA; Sullivan G; Hutchins CW; O'Conner S; Gentiles R; Sowin T; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Jan; 15(1):153-8. PubMed ID: 15582430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the synthesis of phomoidride D.
    Murphy GK; Shirahata T; Hama N; Bedermann A; Dong P; McMahon TC; Twenter BM; Spiegel DA; McDonald IM; Taniguchi N; Inoue M; Wood JL
    J Org Chem; 2013 Jan; 78(2):477-89. PubMed ID: 23245580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.